[go: up one dir, main page]

EE200000741A - Kompositsioon osteoporoosi ja menopausi sündroomist tingitud muutuste ennetamiseks ja/või raviks - Google Patents

Kompositsioon osteoporoosi ja menopausi sündroomist tingitud muutuste ennetamiseks ja/või raviks

Info

Publication number
EE200000741A
EE200000741A EEP200000741A EEP200000741A EE200000741A EE 200000741 A EE200000741 A EE 200000741A EE P200000741 A EEP200000741 A EE P200000741A EE P200000741 A EEP200000741 A EE P200000741A EE 200000741 A EE200000741 A EE 200000741A
Authority
EE
Estonia
Prior art keywords
osteoporosis
prevention
treatment
composition
changes caused
Prior art date
Application number
EEP200000741A
Other languages
English (en)
Estonian (et)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of EE200000741A publication Critical patent/EE200000741A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EEP200000741A 1998-06-23 1999-06-17 Kompositsioon osteoporoosi ja menopausi sündroomist tingitud muutuste ennetamiseks ja/või raviks EE200000741A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000417A IT1299191B1 (it) 1998-06-23 1998-06-23 Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
PCT/IT1999/000174 WO1999066913A2 (fr) 1998-06-23 1999-06-17 Composition utilisee dans la prevention et/ou le traitement de l'osteoporose et modifications induites par le syndrome de la menopause

Publications (1)

Publication Number Publication Date
EE200000741A true EE200000741A (et) 2002-04-15

Family

ID=11406005

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000741A EE200000741A (et) 1998-06-23 1999-06-17 Kompositsioon osteoporoosi ja menopausi sündroomist tingitud muutuste ennetamiseks ja/või raviks

Country Status (27)

Country Link
US (1) US6335038B1 (fr)
EP (1) EP1089742B1 (fr)
JP (1) JP4430233B2 (fr)
KR (1) KR20010071541A (fr)
CN (1) CN1306434A (fr)
AR (1) AR018924A1 (fr)
AT (1) ATE228367T1 (fr)
AU (1) AU755272B2 (fr)
BR (1) BR9911440A (fr)
CA (1) CA2334875C (fr)
DE (1) DE69904172T2 (fr)
DK (1) DK1089742T3 (fr)
EE (1) EE200000741A (fr)
ES (1) ES2188177T3 (fr)
HU (1) HU224957B1 (fr)
IL (1) IL140163A0 (fr)
IS (1) IS5764A (fr)
IT (1) IT1299191B1 (fr)
MA (1) MA26655A1 (fr)
NO (1) NO20006431L (fr)
NZ (1) NZ508877A (fr)
PL (1) PL192118B1 (fr)
PT (1) PT1089742E (fr)
SK (1) SK19292000A3 (fr)
TN (1) TNSN99132A1 (fr)
TR (1) TR200003735T2 (fr)
WO (1) WO1999066913A2 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
US6476010B2 (en) * 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
AU2001245977A1 (en) * 2000-03-23 2001-10-03 Interhealth Nutraceuticals Incorporated Method and composition for preventing or reducing the symptoms of menopause
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
IT1317079B1 (it) * 2000-12-21 2003-05-26 Sigma Tau Ind Farmaceuti Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi.
CN1638650A (zh) * 2001-03-09 2005-07-13 雀巢制品公司 改善与年龄有关的生理缺陷并延长寿命的组合物
EP1370257B1 (fr) * 2001-03-15 2007-07-25 DSM IP Assets B.V. COMPOSITION DESTINEE A LA PREVENTION DE L'OSTEOPOROSE consistant en UNE COMBINAISON D'ISOFLAVONES ET D'ACIDES GRAS POLYINSATURES
AUPR957001A0 (en) * 2001-12-19 2002-01-24 Novogen Research Pty Ltd Isoflavone conjugates, derivatives thereof and therapeutic methods involving same
EP1474129A1 (fr) * 2002-02-15 2004-11-10 N.V. Nutricia Utilisation de genisteine dans la fabrication d'un medicament destine au traitement de l'osteoporose et de l'obesite, et compositions contenant de la genisteine combinee a de la vitamine d et a de la vitamine k
KR100542478B1 (ko) * 2002-08-28 2006-01-11 한경대학교 산학협력단 석류 유래 피토에스트로겐을 함유하는 건강기능식품
EP1581199B1 (fr) * 2002-09-09 2015-02-25 Nestec S.A. Composition par voie orale d'amelioration de la qualite de la peau
KR100520408B1 (ko) * 2003-03-25 2005-10-10 주식회사 태평양 비만개선용 조성물
DK2218342T3 (en) * 2003-05-27 2018-10-22 Dsm Ip Assets Bv New nutraceutical compositions and their use
JP2005187454A (ja) * 2003-12-05 2005-07-14 Sankyo Co Ltd ビタミンｅ含有ｌｄｌ低下剤及び／又は動脈硬化抑制剤組成物
US20080305094A1 (en) * 2004-01-28 2008-12-11 Nestec S.A. Nutritional Composition for Improving Skin Condition and Preventing Skin Diseases
US7666913B2 (en) 2004-02-03 2010-02-23 Kotosugi Inc. Method of treating or preventing osteoporosis using isotaxiresinol derived from Taxus yunnanensis
WO2005089567A1 (fr) * 2004-03-17 2005-09-29 Nestec S.A. Compositions et methodes permettant de reduire ou de prevenir l'obesite
CN100351248C (zh) * 2004-07-05 2007-11-28 南京大学 染料木素衍生物及其制法和用途
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
DE102004060314A1 (de) * 2004-12-08 2006-08-31 Beiersdorf Ag Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen
CA2592389C (fr) 2004-12-29 2013-05-14 Hill's Pet Nutrition, Inc. Methodes permettant d'inhiber un declin des facultes d'apprentissage et/ou de la memoire chez les animaux
CA2593335A1 (fr) * 2005-01-10 2006-07-13 Hormos Medical Ltd. Emploi d'une lignane dans l'elaboration d'une preparation destinee a prevenir ou soulager les symptomes d'une insuffisance en oestrogenes
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
AU2006268787B2 (en) * 2005-07-08 2012-02-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of a combination comprising L-carnitine or alkanoyl L-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases
JP5284087B2 (ja) 2005-07-14 2013-09-11 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物の生命を延長するための方法
CN1939534B (zh) * 2005-09-27 2010-12-01 长春金赛药业股份有限公司 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
US20080262081A1 (en) * 2005-10-14 2008-10-23 Daniel Raederstorff Novel Use of Nutraceutical Compositions Comprising Resveratrol
BRPI0618222A2 (pt) * 2005-11-02 2011-08-23 Nestec Sa composições de isoflavona para reduzir o acúmulo de gordura corporal em animais machos, e métodos para seu uso
RU2403036C2 (ru) 2006-02-28 2010-11-10 Нестек С.А. Композиция и способы стимулирования роста костей и ингибирования разрушения костей
JP2009536610A (ja) * 2006-02-28 2009-10-15 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ 骨疾患の予防／治療のための医薬組成物及びその調製方法
EP2004169B1 (fr) * 2006-04-12 2012-08-08 Unilever PLC Composition orale comprenant un acide gras polyinsaturé et de l'acide salicylique destinée à produire un effet anti-inflammatoire dans la peau
EP2189155B1 (fr) * 2006-04-12 2016-01-06 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Composition orale pour traiter les signes cutanés du vieillissement
US20090286872A1 (en) * 2006-04-12 2009-11-19 John Casey Oral Composition Comprising Dha and Genistein for Enchancing Skin Properties
US20080108696A1 (en) 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
US8680140B2 (en) * 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
WO2008100560A2 (fr) * 2007-02-14 2008-08-21 University Of Southern California Modulateurs de récepteur d'œstrogène, compositions pharmaceutiques associées et procédés d'utilisation
RU2509768C2 (ru) 2008-09-10 2014-03-20 Асахи Гласс Компани, Лимитед Новое производное простагландина i2
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
MX2011004666A (es) * 2008-11-11 2011-05-31 Sigma Tau Ind Farmaceuti Compuesto util para tratar celulitis.
KR101158856B1 (ko) 2009-05-12 2012-06-25 한국생명공학연구원 콩잎 추출물 또는 이의 분획물을 유효성분으로 함유하는 비만, 고지혈증, 동맥경화, 지방간, 당뇨 또는 대사증후군의 예방 또는 치료용 조성물
CN102917703B (zh) * 2010-03-08 2015-08-19 科研制药株式会社 新型ep4激动剂
US20130203848A1 (en) * 2010-06-16 2013-08-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compounds useful for increasing neurogenesis in neural tissue
WO2012011572A1 (fr) * 2010-07-23 2012-01-26 国立大学法人大阪大学 Agent thérapeutique pour insuffisance cardiaque diastolique
IT201700116392A1 (it) * 2018-04-03 2019-10-03 Composizione per somministrazione orale aventi benefico effetto sulla salute della donna in menopausa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1275434B (it) * 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
US5702752A (en) * 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
US6139872A (en) * 1996-08-14 2000-10-31 Henkel Corporation Method of producing a vitamin product
CA2280093A1 (fr) * 1997-02-04 1998-08-06 John V. Kosbab Compositions et procedes destines a la prevention et au traitement de maladies degeneratives vasculaires

Also Published As

Publication number Publication date
US6335038B1 (en) 2002-01-01
WO1999066913A2 (fr) 1999-12-29
BR9911440A (pt) 2001-03-20
NO20006431L (no) 2001-02-22
TNSN99132A1 (fr) 2005-11-10
MA26655A1 (fr) 2004-12-20
EP1089742B1 (fr) 2002-11-27
PT1089742E (pt) 2003-04-30
PL345030A1 (en) 2001-11-19
ATE228367T1 (de) 2002-12-15
NO20006431D0 (no) 2000-12-15
JP2002518437A (ja) 2002-06-25
DE69904172D1 (de) 2003-01-09
DE69904172T2 (de) 2003-08-28
DK1089742T3 (da) 2003-03-24
ES2188177T3 (es) 2003-06-16
HU224957B1 (en) 2006-04-28
TR200003735T2 (tr) 2001-03-21
AU755272B2 (en) 2002-12-05
ITRM980417A1 (it) 1999-12-23
IS5764A (is) 2000-12-08
AR018924A1 (es) 2001-12-12
EP1089742A2 (fr) 2001-04-11
CA2334875A1 (fr) 1999-12-29
NZ508877A (en) 2002-09-27
WO1999066913A3 (fr) 2000-04-20
CA2334875C (fr) 2009-05-12
PL192118B1 (pl) 2006-09-29
ITRM980417A0 (it) 1998-06-23
IL140163A0 (en) 2002-02-10
HUP0102879A3 (en) 2002-12-28
IT1299191B1 (it) 2000-02-29
CN1306434A (zh) 2001-08-01
AU4390999A (en) 2000-01-10
HUP0102879A2 (hu) 2002-03-28
KR20010071541A (ko) 2001-07-28
JP4430233B2 (ja) 2010-03-10
SK19292000A3 (sk) 2001-08-06

Similar Documents

Publication Publication Date Title
EE200000741A (et) Kompositsioon osteoporoosi ja menopausi sündroomist tingitud muutuste ennetamiseks ja/või raviks
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
FI956228L (fi) Sisäänhengitykseen tarkoitettuja koostumuksia
DE60010456D1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
DE69520639D1 (de) Desinfizierende Zusammensetzung
PT1066027E (pt) Composicao farmaceutica de topiramato
DE69723277D1 (de) Dampfsterilisierungsanzeigdende zusammensetzungen
ID29262A (id) Komposisi farmasi
DK42099A (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
NO995500D0 (no) Anvendelse av en farmasöytisk sammensetning til behandling av/eller forhindring av ischemi
FI951856A7 (fi) Farmaseuttinen koostumus osteoporoosin hoitamiseksi
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
IT1289581B1 (it) Miscela,composizione per la protezione delle piante contenente la miscela e suo impiego
DE60016836D1 (de) Resistzusammensetzung
BR9813996A (pt) 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
FI955145L (fi) Nasaaliset aromaattiset vapauttavat koostumukset
FI961380A7 (fi) Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitam iseksi
ID30516A (id) Senyawa-senyawa (aminoiminometil atau aminometil) benzoheteroaril tersubstitusi
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
DE69905214D1 (de) Mittel zur Behandlung der Osteoporose
TR200001290T2 (tr) Estrojen mahrumiyet sendromunu tedavi etmek için yararlı 2-aril-3-aroilbenzo(b) tiofenler.
PT853959E (pt) Composicao para o tratamento do amianto
BR9503633A (pt) Composição desinfetante